Ruby Alonso

918 total citations
22 papers, 661 citations indexed

About

Ruby Alonso is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ruby Alonso has authored 22 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Ruby Alonso's work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and Immunotherapy and Immune Responses (6 papers). Ruby Alonso is often cited by papers focused on Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and Immunotherapy and Immune Responses (6 papers). Ruby Alonso collaborates with scholars based in Cuba, France and Spain. Ruby Alonso's co-authors include Enrique Montero, Olivier Lantz, Virginie Prémel, Marion Salou, Aurélie Darbois, Laurie Menger, Yves Renaudineau, Pierre Youinou, Jules Gilet and Anne‐Gaëlle Goubet and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Ruby Alonso

20 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruby Alonso Cuba 14 422 209 152 81 48 22 661
Ryan Schlimgen United States 10 263 0.6× 119 0.6× 171 1.1× 59 0.7× 76 1.6× 11 530
Weiwei Ma China 11 451 1.1× 124 0.6× 122 0.8× 30 0.4× 41 0.9× 25 651
Srinivas Mamidi Germany 14 485 1.1× 177 0.8× 391 2.6× 112 1.4× 28 0.6× 21 868
Hart S. Dengler United States 7 448 1.1× 101 0.5× 249 1.6× 25 0.3× 53 1.1× 7 666
Soo-Jeet Teh Canada 20 818 1.9× 181 0.9× 229 1.5× 53 0.7× 56 1.2× 26 1.1k
Julie Mussard France 10 504 1.2× 163 0.8× 194 1.3× 22 0.3× 39 0.8× 13 680
Takuji Yamauchi Japan 13 288 0.7× 184 0.9× 231 1.5× 22 0.3× 56 1.2× 50 772
Jan Kubach Germany 9 798 1.9× 156 0.7× 222 1.5× 27 0.3× 44 0.9× 9 1.0k
С. В. Сенников Russia 17 556 1.3× 269 1.3× 283 1.9× 95 1.2× 84 1.8× 143 931
Ralf W. Denfeld Germany 13 645 1.5× 224 1.1× 110 0.7× 145 1.8× 31 0.6× 19 911

Countries citing papers authored by Ruby Alonso

Since Specialization
Citations

This map shows the geographic impact of Ruby Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Alonso more than expected).

Fields of papers citing papers by Ruby Alonso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Alonso. The network helps show where Ruby Alonso may publish in the future.

Co-authorship network of co-authors of Ruby Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Alonso. A scholar is included among the top collaborators of Ruby Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Alonso. Ruby Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alonso, Ruby, Zacarias Garcia, Béatrice Corre, et al.. (2025). Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control. Science Advances. 11(33). eadv0871–eadv0871.
2.
Guérin, Marion V., Béatrice Corre, Ruby Alonso, et al.. (2024). Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes. The Journal of Experimental Medicine. 221(4). 12 indexed citations
3.
Boulch, Morgane, Marine Cazaux, Alexis Cuffel, et al.. (2023). Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity. Nature Cancer. 4(7). 968–983. 67 indexed citations
4.
Caudana, Pamela, Nicolás Gonzalo Núñez, Philippe De La Rochère, et al.. (2019). IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell Modulation. Cancer Immunology Research. 7(3). 443–457. 17 indexed citations
5.
Alonso, Ruby, Héloïse Flament, Sébastien Lemoine, et al.. (2018). Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node. Nature Communications. 9(1). 2113–2113. 70 indexed citations
6.
Salou, Marion, François Legoux, Jules Gilet, et al.. (2018). A common transcriptomic program acquired in the thymus defines tissue residency of MAIT and NKT subsets. The Journal of Experimental Medicine. 216(1). 133–151. 135 indexed citations
7.
Dantec, Christelle Le, Ruby Alonso, Tinhinane Fali, et al.. (2013). Rationale for treating primary Sjögren’s syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab). Immunologic Research. 56(2-3). 341–347. 18 indexed citations
8.
Saborit-Villarroya, Ifigènia, Gaël Roué, Mònica López‐Guerra, et al.. (2010). Cell Death Targeting Therapies in B Lymphoid Malignancies. Current Drug Targets. 11(7). 769–780. 1 indexed citations
9.
Alonso, Ruby, Christelle Le Dantec, Sophie Hillion, et al.. (2010). Aberrant expression of CD6 on B-cell subsets from patients with Sjögren’s syndrome. Journal of Autoimmunity. 35(4). 336–341. 44 indexed citations
10.
Pentón‐Rol, Giselle, Gregorio Martı́nez-Sánchez, Ruby Alonso, et al.. (2010). C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. International Immunopharmacology. 11(1). 29–38. 50 indexed citations
11.
Alonso, Ruby, Séverine Loisel, Jacques‐Olivier Pers, et al.. (2010). Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases. PubMed. 2010. 1–9. 27 indexed citations
12.
López‐Requena, Alejandro, et al.. (2010). Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells. Molecular Immunology. 48(1-3). 98–108. 1 indexed citations
13.
Renaudineau, Yves, et al.. (2010). Autoreactive B cells and epigenetics.. SPIRE - Sciences Po Institutional REpository. 3 indexed citations
14.
Abraham, Consuelo Macías, et al.. (2009). Expresión fenotípica de las moléculas CD5 y CD6 en la leucemia linfoide crónica B-CD5+. Revista Cubana de Hematología, Inmunología y Hemoterapia. 25(1). 0–0.
15.
Gil, Luiz Fernando, Carolina B. López, Laura Lazo, et al.. (2009). Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice. International Immunology. 21(10). 1175–1183. 27 indexed citations
16.
Renaudineau, Yves, Soizic Garaud, Christelle Le Dantec, et al.. (2009). Autoreactive B Cells and Epigenetics. Clinical Reviews in Allergy & Immunology. 39(1). 85–94. 19 indexed citations
17.
Gil, Lázaro, et al.. (2009). A CFSE-based assay of proliferative response of lymphocytes to stimulation with dengue viruses. Acta Virologica. 53(3). 147–152. 2 indexed citations
18.
Pentón‐Rol, Giselle, et al.. (2008). Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients. International Immunopharmacology. 8(6). 881–886. 15 indexed citations
19.
Blanco, Rancés, et al.. (2007). Biological Activity In Vitro of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies with Different Affinities. Hybridoma. 26(6). 423–432. 42 indexed citations
20.
Alfonso, Mauro, Ruby Alonso, Giselle Saurez, et al.. (2003). Immune responses in breast cancer patients immunized with an anti-idiotype antibody mimicking NeuGc-containing gangliosides. Clinical Immunology. 107(2). 80–89. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan Schlimgen Breakdown of academic impact, for papers by Weiwei Ma Breakdown of academic impact, for papers by Srinivas Mamidi Breakdown of academic impact, for papers by Hart S. Dengler Breakdown of academic impact, for papers by Soo-Jeet Teh Breakdown of academic impact, for papers by Julie Mussard Breakdown of academic impact, for papers by Takuji Yamauchi Breakdown of academic impact, for papers by Jan Kubach Breakdown of academic impact, for papers by С. В. Сенников Breakdown of academic impact, for papers by Ralf W. Denfeld
Rankless by CCL
2026